메뉴 건너뛰기




Volumn 15, Issue 10, 2013, Pages 1395-1404

Quantitative T2 mapping of recurrent glioblastoma under bevacizumab improves monitoring for non-enhancing tumor progression and predicts overall survival

Author keywords

bevacizumab; non enhancing tumor; quantitative MRI; T2 relaxation time

Indexed keywords

BEVACIZUMAB; IRINOTECAN; TEMOZOLOMIDE;

EID: 84885015454     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/not105     Document Type: Article
Times cited : (85)

References (25)
  • 2
    • 70350461699 scopus 로고    scopus 로고
    • Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma
    • Friedman HS, Prados MD,Wen PY, et al. Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma. J Clin Oncol. 2009;27(28):4733-4740.
    • (2009) J Clin Oncol , vol.27 , Issue.28 , pp. 4733-4740
    • Friedman, H.S.1    Prados, M.D.2    Wen, P.Y.3
  • 5
    • 67649974030 scopus 로고    scopus 로고
    • End point assessment in gliomas: Novel treatments limit usefulness of classical Macdonald's criteria
    • van den Bent MJ, Vogelbaum MA,Wen PY, Macdonald DR, Chang SM. End point assessment in gliomas: novel treatments limit usefulness of classical Macdonald's criteria. J Clin Oncol. 2009;27(18):2905-2908.
    • (2009) J Clin Oncol , vol.27 , Issue.18 , pp. 2905-2908
    • Van Den Bent, M.J.1    Vogelbaum, M.A.2    Wen, P.Y.3    Macdonald, D.R.4    Chang, S.M.5
  • 6
    • 74049087788 scopus 로고    scopus 로고
    • Pseudoprogression and pseudoresponse in the treatment of gliomas
    • Brandsma D, van den Bent MJ. Pseudoprogression and pseudoresponse in the treatment of gliomas. Curr Opin Neurol. 2009;22(6):633-638. Review.
    • (2009) Curr Opin Neurol , vol.22 , Issue.6 , pp. 633-638
    • Brandsma, D.1    Van Den Bent, M.J.2
  • 7
    • 77951625266 scopus 로고    scopus 로고
    • Updated response assessment criteria for high-grade gliomas: Response Assessment in Neuro-Oncology working group
    • Wen PY, Macdonald DR, Reardon DA, et al. Updated response assessment criteria for high-grade gliomas: Response Assessment in Neuro-Oncology working group. J Clin Oncol. 2010;28(11):1963-1972.
    • (2010) J Clin Oncol , vol.28 , Issue.11 , pp. 1963-1972
    • Wen, P.Y.1    Macdonald, D.R.2    Reardon, D.A.3
  • 9
    • 0027008434 scopus 로고
    • 2 relaxation of experimental brain tumors in the cat: A multiparameter tissue characterization
    • DOI 10.1016/0730-725X(92)90448-9
    • Hoehn-Berlage M, Tolxdorff T, Bockhorst K, Okada Y, Ernestus RI. In vivo NMRT2 relaxation of experimental brain tumors in the cat: a multiparameter tissue characterization. Magn Reson Imaging. 1992;10(6):935-947. (Pubitemid 23082027)
    • (1992) Magnetic Resonance Imaging , vol.10 , Issue.6 , pp. 935-947
    • Hoehn-Berlage, M.1    Tolxdorff, T.2    Bockhorst, K.3    Okada, Y.4    Ernestus, R.-I.5
  • 10
    • 0028839868 scopus 로고
    • High resolution quantitative relaxation and diffusion MRI of three different experimental brain tumors in rat
    • EisM,Els T,Hoehn-BerlageM.High resolution quantitative relaxation and diffusion MRI of three different experimental brain tumors in rat. Magn Reson Med. 1995;34(6):835-844.
    • (1995) Magn Reson Med , vol.34 , Issue.6 , pp. 835-844
    • Eis, M.1    Els, T.2    Hoehn-Berlage, M.3
  • 11
    • 83055181491 scopus 로고    scopus 로고
    • Quantification of edema reduction using differential quantitative T2 (DQT2) relaxometry mapping in recurrent glioblastoma treated with bevacizumab
    • Ellingson BM, Cloughesy TF, Lai A, et al. Quantification of edema reduction using differential quantitative T2 (DQT2) relaxometry mapping in recurrent glioblastoma treated with bevacizumab. J Neurooncol. 2012;106(1):111-119.
    • (2012) J Neurooncol , vol.106 , Issue.1 , pp. 111-119
    • Ellingson, B.M.1    Cloughesy, T.F.2    Lai, A.3
  • 12
    • 84856302564 scopus 로고    scopus 로고
    • Bevacizumab impairs oxidative energy metabolism and shows antitumoral effects in recurrent glioblastomas: A 31P/1H MRSI and quantitative magnetic resonance imaging study
    • Hattingen E, Jurcoane A, Bähr O, et al. Bevacizumab impairs oxidative energy metabolism and shows antitumoral effects in recurrent glioblastomas: a 31P/1H MRSI and quantitative magnetic resonance imaging study. Neuro Oncol. 2011;13(12):1349-1363.
    • (2011) Neuro Oncol , vol.13 , Issue.12 , pp. 1349-1363
    • Hattingen, E.1    Jurcoane, A.2    Baöhr, O.3
  • 13
    • 80052965850 scopus 로고    scopus 로고
    • Quantitative T 2-mapping based on multi-slice multiple gradient echo flash imaging: Retrospective correction for subject motion effects
    • Magerkurth J, Volz S, Wagner M, et al. Quantitative T*2-mapping based on multi-slice multiple gradient echo flash imaging: retrospective correction for subject motion effects. Magn Reson Med. 2011;66(4): 989-997.
    • (2011) Magn Reson Med , vol.66 , Issue.4 , pp. 989-997
    • Magerkurth, J.1    Volz, S.2    Wagner, M.3
  • 14
    • 79954441652 scopus 로고    scopus 로고
    • Signal intensity in T2? Magnetic resonance imaging is related to brain glioma grade
    • Saitta L, Heese O, FörsterAF, Matschke J, et al. Signal intensity in T2? magnetic resonance imaging is related to brain glioma grade. Eur Radiol. 2011;21(5):1068-1076.
    • (2011) Eur Radiol , vol.21 , Issue.5 , pp. 1068-1076
    • Saitta, L.1    Heese, O.2    Förster, A.F.3    Matschke, J.4
  • 15
    • 0025336246 scopus 로고
    • Oxygenation-sensitive contrast in magnetic resonance image of rodent brain at high magnetic fields
    • DOI 10.1002/mrm.1910140108
    • Ogawa S, Lee TM, Nayak AS, Glynn P. Oxygenation-sensitive contrast in magnetic resonance image of rodent brain at high magnetic fields. Magn Reson Med. 1990;14(1):68-78. (Pubitemid 20243866)
    • (1990) Magnetic Resonance in Medicine , vol.14 , Issue.1 , pp. 68-78
    • Ogawa, S.1    Lee, T.-M.2    Nayak, A.S.3    Glynn, P.4
  • 18
    • 53749087689 scopus 로고    scopus 로고
    • Relationship between gene expression and enhancement in glioblastoma multiforme: Exploratory DNA microarray analysis
    • Pope WB, Chen JH, Dong J, et al. Relationship between gene expression and enhancement in glioblastoma multiforme: exploratory DNA microarray analysis. Radiology. 2008;249(1):268-277.
    • (2008) Radiology , vol.249 , Issue.1 , pp. 268-277
    • Pope, W.B.1    Chen, J.H.2    Dong, J.3
  • 21
    • 79956061552 scopus 로고    scopus 로고
    • Response assessment in neuro-oncology criteria: Implementation challenges in multicenter neuro-oncology trials
    • Pope WB, Hessel C. Response assessment in neuro-oncology criteria: implementation challenges in multicenter neuro-oncology trials. AJNRAmJ Neuroradiol. 2011;32(5):794-797.
    • (2011) AJNRAmJ Neuroradiol , vol.32 , Issue.5 , pp. 794-797
    • Pope, W.B.1    Hessel, C.2
  • 22
    • 0035142330 scopus 로고    scopus 로고
    • Effect of T1 relaxation time on lesion contrast enhancement in flair MR imaging: A study using computer-generated brain maps
    • Melhem ER, Itoh R. Effect of T1 relaxation time on lesion contrast enhancement in FLAIR MR imaging: a study using computer-generated brain maps. AJR Am J Roentgenol. 2001;176(2):537-539. (Pubitemid 32105678)
    • (2001) American Journal of Roentgenology , vol.176 , Issue.2 , pp. 537-539
    • Melhem, E.R.1    Itoh, R.2
  • 23
    • 79952740612 scopus 로고    scopus 로고
    • Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma
    • Keunen O, Johansson M, Oudin A, et al. Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma. Proc Natl Acad Sci U S A. 2011;108(9):3749-3754.
    • (2011) Proc Natl Acad Sci U S A , vol.108 , Issue.9 , pp. 3749-3754
    • Keunen, O.1    Johansson, M.2    Oudin, A.3
  • 24
    • 78651408563 scopus 로고    scopus 로고
    • Glioblastoma recurrence after cediranib therapy in patients: Lack of 'rebound' revascularization as mode of escape
    • di Tomaso E, Snuderl M, Kamoun WS, et al. Glioblastoma recurrence after cediranib therapy in patients: lack of 'rebound' revascularization as mode of escape. Cancer Res. 2011;71(1):19-28.
    • (2011) Cancer Res , vol.71 , Issue.1 , pp. 19-28
    • Di Tomaso, E.1    Snuderl, M.2    Kamoun, W.S.3
  • 25
    • 84899833526 scopus 로고    scopus 로고
    • Bevacizumab failure in glioblastomas [Meeting Abstracts
    • Tabatabai G, Felsberg J, Sabel M, et al. Bevacizumab failure in glioblastomas [Meeting Abstracts]. J Clin Oncol. 2012;30(15):2067.
    • (2012) J Clin Oncol , vol.30 , Issue.15 , pp. 2067
    • Tabatabai, G.1    Felsberg, J.2    Sabel, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.